WHO Grade 3 Emergencies [to 18 February 2017]
Iraq: Urgently needed medicines and medical supplies delivered to east Mosul
Erbil 15 February 2017 – The World Health Organization (WHO) has responded to an acute shortage of medical supplies in the newly retaken areas of Mosul by delivering medicines and other medical supplies to 16 primary health centers, one hospital and the Directorate of Health (DOH) in Ninewa. The donation will support treatment of patients with infectious diseases, chronic conditions, diarrheal diseases and trauma cases who have been deprived of medical care.
WHO teams assist people in hard-to-reach areas of Nigeria
17 February 2017 – Medical teams supported by WHO set up mobile clinics in hard to access areas of north-eastern Nigeria. The teams are called “hard-to-reach” teams (HTR) because their mission is to reach remote and insecure areas to provide urgently needed care to populations deprived of essential health services. The 8-year conflict has caused widespread forced displacement and acute food and nutrition insecurity. Large areas of Borno state, the most-affected state, remain inaccessible to humanitarian assistance.
:: WHO responds to health needs of populations fleeing conflict in Yemen
February 2017 – As violent conflict continues in Al-Mokha City in Taizz governorate, Yemen, more than more than 8000 internally displaced persons have fled to several other districts. WHO teams in are providing trauma care and primary health care services to newly displaced persons, and delivering medicines and supplies to health facilities.
WHO Grade 2 Emergencies [to 18 February 2017]
Cameroon – No new announcements identified.
Central African Republic – No new announcements identified.
Democratic Republic of the Congo – No new announcements identified.
Ethiopia – No new announcements identified.
Libya – No new announcements identified.
Myanmar – No new announcements identified.
Niger – No new announcements identified.
Ukraine – No new announcements identified.
UN OCHA – L3 Emergencies
The UN and its humanitarian partners are currently responding to three ‘L3’ emergencies. This is the global humanitarian system’s classification for the response to the most severe, large-scale humanitarian crises.
:: Iraq: Mosul Humanitarian Response Situation Report No. 20 (6 February – 12 February 2017)
POLIO [to 18 February 2017]
Public Health Emergency of International Concern (PHEIC)
Polio this week as of 15 February 2017
:: The 12th meeting of the Emergency Committee under the International Health Regulations (IHR) met on 7 February and concluded that current global polio epidemiology continues to constitute a Public Health Emergency of International Concern (PHEIC). The Temporary Recommendations promulgated under the IHR remain in effect. National polio emergency action plans continue to be implemented in all countries affected by circulation of either wild poliovirus or vaccine-derived poliovirus, and all countries currently thus affected have declared these events to be a national public health emergency…
Country Updates [Selected Excerpts]
:: One new environmental WPV1 positive sample was reported in the past week, from Killa Abdullah, Balochistan, collected on 19 January.
Twelfth meeting of the Emergency Committee under the International Health Regulations (2015) regarding the international spread of poliovirus
13 February 2017 – The twelfth meeting of the Emergency Committee (EC) under the International Health Regulations (2005) (IHR) regarding the international spread of poliovirus was convened via teleconference by the Director General on 7 February 2017.
[See more detail in Milestones/Perspectives above]
We will cluster these recent emergencies as below and continue to monitor the WHO webpages for updates and key developments.
Zika virus [to 18 February 2017]
Latest Report [now bi-weekly]:
Zika situation report – 2 February 2017
Full report: http://apps.who.int/iris/bitstream/10665/254507/1/zikasitrep2Feb17-eng.pdf?ua=1
Overall, the global risk assessment has not changed. Zika virus continues to spread geographically to areas where competent vectors are present. Although a decline in cases of Zika infection has been reported in some countries, or in some parts of countries, vigilance needs to remain high.
Yellow Fever [to 18 February 2017]
WHO: The yellow fever outbreak in Angola and Democratic Republic of the Congo ends
Brazzaville, 14 February 2017 – The Democratic Republic of Congo (DRC) declared the end of the yellow fever outbreak in that country today following a similar announcement in Angola on 23 December 2016, bringing an end to the outbreak in both countries after no new confirmed cases were reported from both countries for the past six months.
“We are able to declare the end of one of the largest and most challenging yellow fever outbreak in recent years through the strong and coordinated response by national authorities, local health workers and partners,” said Dr Matshidiso Moeti, the World Health Organization (WHO) Regional Director for Africa, commending the unprecedented and immense response to the outbreak.
The outbreak, which was first detected in Angola in December 2015, had caused 965 confirmed cases of yellow fever across the two countries, with thousands more cases suspected. The last case detected in Angola was on 23 June 2016 and DRC’s last case was on 12 July the same year.
More than 30 million people were vaccinated in the two countries in emergency vaccination campaigns. This key part of the response included mop up and preventative campaigns in hard to reach areas up until the end of the year to ensure vaccine protection for as many people in all areas of risk as possible. This unprecedented response exhausted the global stockpile of yellow fever vaccines several times.
More than 41,000 volunteers and 8,000 vaccination teams with more than 56 NGO partners were involved in the mass immunization campaigns. The vaccines used came from a global stockpile co-managed by Médecins Sans Frontières (MSF), International Federation of the Red Cross and Red Crescent Societies (IFRC), UNICEF and WHO. In the first 6 months of 2016 alone, the partners delivered more than 19 million doses of the vaccine – three times the 6 million doses usually put aside for an outbreak. Gavi, the Vaccine Alliance financed a significant proportion of the vaccines…
EBOLA/EVD [to 18 February 2017]
No new digest content identified for this edition.
MERS-CoV [to 18 February 2017]
No new digest content identified for this edition.